The pharmaceutical industry relies heavily on the precision and purity of its raw materials and intermediates. For the production of apixaban, a blockbuster anticoagulant, the intermediate Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate (CAS 27143-07-3) is of utmost importance. Ensuring the highest purity of this compound is not just a preference but a necessity for efficient and effective drug manufacturing. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying this intermediate with the quality demanded by the pharmaceutical sector.

Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate, with the chemical formula C11H13ClN2O3, is a key building block in the synthetic route to apixaban. Its molecular weight is approximately 256.69 g/mol. The compound typically presents as a solid, often described as light yellow to dark yellow. The critical aspect for its application is its purity, which needs to be consistently high, often specified as ≥99%. Impurities, even in small amounts, can interfere with subsequent reaction steps, reduce the yield of apixaban, and potentially lead to unwanted byproducts that are difficult to remove, impacting the final drug's safety and efficacy. Therefore, reliable apixaban precursor manufacturing requires intermediates produced under stringent controls.

The synthesis pathway for Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate involves careful chemical reactions, typically starting from p-anisidine. The precise nature of this synthesis is crucial for achieving the desired purity. When sourcing this intermediate, it is vital to partner with suppliers who understand the critical quality attributes required for pharmaceutical applications. As a dedicated pharmaceutical intermediate supplier China, NINGBO INNO PHARMCHEM CO.,LTD. invests in advanced manufacturing processes and rigorous quality control systems to guarantee the purity and consistency of this essential chemical.

The impact of intermediate purity on the final API is significant. Lower purity can lead to increased purification costs, longer production times, and potential regulatory hurdles. For companies engaged in the pharmaceutical intermediate manufacturing of apixaban, securing a dependable source of high-purity Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate is a strategic imperative. This focus on quality minimizes risks and optimizes the overall production efficiency. The ability to procure this compound at a competitive price from a trusted supplier like NINGBO INNO PHARMCHEM CO.,LTD. empowers drug developers to bring vital medicines to market more effectively.

In summary, the role of Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate in the production of apixaban cannot be overstated. Its high purity is a non-negotiable requirement for successful pharmaceutical synthesis. NINGBO INNO PHARMCHEM CO.,LTD. stands as a reliable partner, offering this critical intermediate with the assurance of quality and consistency, supporting the ongoing efforts to combat cardiovascular diseases through advanced pharmaceutical solutions.